sapropterin dihydrochloride (6R-BH4)
WILK1
Phase 1 small_molecule completed
Quick answer
sapropterin dihydrochloride (6R-BH4) for Pulmonary Arterial Hypertension is a Phase 1 program (small_molecule) at BIOMARIN PHARMACEUTICAL INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIOMARIN PHARMACEUTICAL INC
- Indication
- Pulmonary Arterial Hypertension
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed